EASL – The Digital International Liver Congress 2020

Published on 26/08/2020

August 27-29, 2020
Digital congress

ENYO Pharma was connected from the 27th to the 29th of August at the digital EASL International Liver Congress and present 2 posters.

“Characterization of EYP001 a novel, potent and selective FXR agonist in in vitro 3D human liver models”

“A novel small molecule modulating the mitochondrial NEET (CISD) proteins activity improves inflammation and fibrosis in a diet-induced model of non-alcoholic steatohepatitis”

Read next in 'Events'

• FEDERG meeting - 10 years, 2024
• The 2024 international workshop on Alport syndrome
• Alport Connect 2024, la rencontre annuelle américaine avec les patients atteints du syndrome d’Alport
• ASN Kidney Week 2024
• ASN Kidney Week 2024